Table 3.

Shear rate area under the curve and FMD normalized to SR AUC

	Time
	Baseline	15 min Post	30 min Post	45 min Post
SR AUC*
Placebo
Pre	663 ± 91	623 ± 63	594 ± 75	629 ± 68
Post	683 ± 101	533 ± 60	550 ± 52	579 ± 85
Montmorency cherry
Pre	669 ± 85	525 ± 58	524 ± 47	577 ± 64
Post	632 ± 63	456 ± 54	444 ± 57	544 ± 63
FMD:SR AUC*
Placebo
Pre	0.99 ± 0.16	0.46 ± 0.06	0.66 ± 0.12	0.85 ± 0.12
Post	1.00 ± 0.13	0.67 ± 0.13	0.75 ± 0.10	0.92 ± 0.15
Montmorency cherry
Pre	0.90 ± 0.09	0.49 ± 0.07	0.65 ± 0.10	0.70 ± 0.11
Post	1.06 ± 0.22	0.61 ± 0.09	1.11 ± 0.29	1.15 ± 0.20

Values are expressed as means ± SE. Shear rate area under the curve (SR AUC) and flow-mediated dilation (FMD) were normalized to SR AUC (FMD:SR AUC) measured 15 min before 20-min occlusion (baseline), 15, 30, and 45 min after reperfusion and before and after each supplementation block.

^*Main effect of time, P < 0.001.